A randomised controlled clinical study on Ayurveda intervention (Ayush 64, Sanshamani Vati and Vatashleshma Jwarhar Kwatha) along with Standard Care Treatment in mild to moderate patients of COVID-19

Dr SR Rajasthan Ayurved University Jodhpur0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

研究概览

暂无简介。

•1.All hospitalized cases 18-60 years of age, clinically diagnosed with corona virus disease 2019 (Covid19) and who are symptomatic and having Mild to moderate symptoms.
•2.Participants who can take medicines orally.
•3.Patients taking standard care treatment
•4.Patients willing to provide signed informed consent.

•1.Cases of severe vomiting which would affect oral administration of medicine difficult.
•2.Cases of respiratory failure and requiring mechanical ventilation.
•3.Patients having Alanine Transaminase (ALT) or Aspartate Transaminase (AST) > 5 times the upper range of normal limits.
•4.Patients with COVID-19 in critical condition or ARDS or NIAD 8 â??point ordinal score-2 (Hospitalized, on invasive mechanical Ventilation or extra corporeal membrane oxygenation
•5.Combined organ failure requiring ICU monitoring.
•6.Patients with uncontrolled Diabetes Mellitus, (HbA1c more than 8.0), Malignant Hypertension (systolic BP more than 180 and diastolic 110), Chronic Renal Failure and those on immunosuppressive medication.
•7.Patients with history of malignancy, IHD, CAD, triple vessel disease, history of CABG, Stroke, etc.
•8.Any other condition, which as per the investigator would jeopardize the outcome of the trial.

发起方

Dr SR Rajasthan Ayurved University Jodhpur